Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

ProBiotix Health anticipating "big commercial opportunities" during 2023

ProBiotix Health anticipating "big commercial opportunities" during 2023

Incoming ProBiotix Health PLC (AQSE:PBX) CEO Steen Anderson and OptiBiotix Health PLC (AIM:OPTI) Group CEO Stephen O’Hara speak to Proactive about how ProBiotix performed in 2022, before looking ahead to what investors can expect from the coming year.

Anderson explains what it was that attracted to him to the CEO role at ProBiotix, and O'Hara reveals the "big commercial opportunities" he expects to come ProBiotix's way in 2023.

ProBiotix Health PLC is an OptiBiotix Health PLC subsidiary.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK